15000 participants
Zanubrutinib and Acalabrutinib Use and Risk of Atrial Fibrillation in Patients With Chronic B-cell Malignancies
- Study Type:
- OBSERVATIONAL
- Last Updated:
- 2025-12-16
- Start Date:
- 2025-12-22
- Completion:
- 2026-01-15
Conditions
- Chronic B-cell Malignancies
- BTK Inhibitors
- Cardiovascular Diseases
Interventions
- DRUG
No Results Yet